Samraat S. Raha is recorded as Board Member at Myriad Genetics Inc (MYGN) since June 5, 2025 and CEO at Myriad Genetics Inc (MYGN) since April 30, 2025. The newest filing on record that lists Samraat S. Raha as Board Member and CEO at Myriad Genetics Inc (MYGN) is dated April 14, 2026. Myriad Genetics Inc reported in an 8-K filed June 5, 2025 that Samraat S. Raha was appointed director, effective June 5, 2025. Myriad Genetics Inc reported in an 8-K filed February 24, 2025 that Samraat S. Raha was appointed President and Chief Executive Officer, effective April 30, 2025. Myriad Genetics Inc reported in an 8-K filed February 24, 2025 that Samraat S. Raha was appointed Class II director, effective April 30, 2025. Equibles holds 4 filed executive changes naming Samraat S. Raha; each is listed under recent activity with its source filing. Samraat S. Raha has spoken on 1 earnings call across 1 company, most recently for Myriad Genetics Inc on July 30, 2026. Myriad Genetics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Myriad Genetics Inc includes R. Bryan Riggsbee (CEO), R. Bryan Riggsbee Chief (CEO), Sam Raha (CEO and Board Member) and 7 others.
“Each of Samraat S. Raha, Heiner Dreismann, PH.D., and Colleen F. Reitan was elected to serve as a director of the Company for a term expiring at the 2028 Annual Meeting of Stockholders, and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, retirement or removal.”
Myriad Genetics Inc Form 8-K, filed June 5, 2025
· Read the filing
“the Board appointed Samraat S. Raha, the Company's Chief Operating Officer, to succeed Mr. Diaz as its President and Chief Executive Officer on the Effective Date.”
Myriad Genetics Inc Form 8-K, filed February 24, 2025
· Read the filing
Samraat S. Raha on recent calls
“Let me dive right into our second quarter performance and key actions we're taking to create a more focused business and can drive accelerated growth and profitability as we go forward.”
